Stockscreener 앱 받기
5.78
0.52%
-0.03
시간 외 거래:
5.77
-0.01
-0.17%
전일 마감가:
$5.81
열려 있는:
$5.8818
하루 거래량:
48,204
Relative Volume:
0.80
시가총액:
$96.67M
수익:
-
순이익/손실:
$-14.88M
주가수익비율:
-5.898
EPS:
-0.98
순현금흐름:
$-10.29M
1주 성능:
-6.17%
1개월 성능:
+5.00%
6개월 성능:
+2.12%
1년 성능:
-17.43%
1일 변동 폭
$5.76
$5.905
1주일 범위
$5.7068
$6.199
52주 변동 폭
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
명칭
Coya Therapeutics Inc
전화
650.739.3939
주소
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
COYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
5.78 | 103.03M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Lake Street | Buy |
| 2024-12-04 | 개시 | D. Boral Capital | Buy |
Coya Therapeutics Inc 주식(COYA)의 최신 뉴스
Is Coya Therapeutics Inc. a good long term investmentTremendous growth opportunities - Autocar Professional
Coya Therapeutics Inc. Stock Analysis and ForecastRapidly growing investment returns - jammulinksnews.com
What drives Coya Therapeutics Inc. stock priceTremendous return rates - Autocar Professional
What analysts say about Coya Therapeutics Inc. stockFree High-Return Strategy Alerts - Autocar Professional
(COYA) Investment Report - news.stocktradersdaily.com
What drives BENFW stock priceConsistent double returns - jammulinksnews.com
What makes Coya Therapeutics Inc. stock price move sharplyLow Risk Trade Timing Signals - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attentionPotential Rocket List - Newser
How Coya Therapeutics Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
Coya Therapeutics (NASDAQ:COYA) Coverage Initiated at Lake Street Capital - Defense World
Coya Therapeutics initiated with a Buy at Lake Street - TipRanks
With CAR Ts and islets raising the bar in I&I, what’s the play for Tregs? - biocentury.com
Positive Outlook for Coya Therapeutics, Inc. Driven by IND Resubmission and Promising Trial Results - TipRanks
Coya Therapeutics (COYA) Receives Continued Buy Rating from Analyst | COYA Stock News - GuruFocus
Coya Therapeutics resubmits IND application for ALS Phase 2 study to FDA - Investing.com
Coya Therapeutics Holds Annual Stockholders Meeting - TipRanks
After myriad failures, a new wave of ALS drugs approaches - Pharma Voice
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025 - Business Wire
Trading (COYA) With Integrated Risk Controls - news.stocktradersdaily.com
Coya Therapeutics (NASDAQ:COYA) Receives Buy Rating from HC Wainwright - Defense World
Coya Therapeutics (COYA) Receives Confirmed Buy Rating from HC W - GuruFocus
Coya Therapeutics (COYA) Receives Confirmed Buy Rating from HC Wainwright | COYA Stock News - GuruFocus
Coya Therapeutics (COYA) Rated Buy by Analyst with $20 Target | COYA Stock News - GuruFocus
Jane Street Group LLC Makes New $74,000 Investment in Coya Therapeutics, Inc. (NASDAQ:COYA) - Defense World
(COYA) Trading Report - news.stocktradersdaily.com
Northern Trust Corp Has $164,000 Stock Position in Coya Therapeutics, Inc. (NASDAQ:COYA) - Defense World
Coya Therapeutics secures patent for IL-2 liquid formulation By Investing.com - Investing.com South Africa
Coya Therapeutics secures patent for IL-2 liquid formulation - Investing.com
Coya Therapeutics (COYA) Secures U.S. Patent for IL-2 Liquid Formulation | COYA Stock News - GuruFocus
Coya's Exclusive Patent Win Strengthens IL-2 Drug Pipeline as Phase 2b ALS Trial Approaches - Stock Titan
Coya Therapeutics Inc (COYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):